Free Trial

NeuroBo Pharmaceuticals (NRBO) SEC Filings & 10K Form

NeuroBo Pharmaceuticals logo
$0.73 -0.02 (-2.39%)
As of 06/13/2025

Recent NeuroBo Pharmaceuticals SEC Filings

DateFilerForm TypeView
06/04/2025
3:01 PM
MetaVia Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
MetaVia Inc. (Issuer)
Woodworth Marshall H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2025
4:06 PM
MetaVia Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
MetaVia Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/27/2025
3:16 PM
MetaVia Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
MetaVia Inc. (Filer)
Form PRE 14A
05/21/2025
7:30 AM
MetaVia Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
MetaVia Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2025
3:15 PM
DONG-A ST CO., LTD (Filed by)
MetaVia Inc. (Subject)
NeuroBo Pharmaceuticals (Subject)
MetaVia Inc. (Subject)
Form SCHEDULE 13D/A
05/20/2025
3:16 PM
DONG-A ST CO., LTD (Reporting)
MetaVia Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
MetaVia Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2025
8:03 AM
MetaVia Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
MetaVia Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2025
6:00 AM
MetaVia Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
MetaVia Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2025
7:33 AM
MetaVia Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
MetaVia Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/15/2025
6:01 AM
MetaVia Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
MetaVia Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/04/2025
6:44 AM
MetaVia Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
MetaVia Inc. (Filer)
Form 424B3
04/03/2025
11:15 PM
MetaVia Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
MetaVia Inc. (Filer)
Form EFFECT
03/27/2025
4:05 PM
MetaVia Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
MetaVia Inc. (Filer)
Form POS AM
03/27/2025
4:07 PM
MetaVia Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
MetaVia Inc. (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/20/2025
4:15 PM
MetaVia Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
MetaVia Inc. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/20/2025
6:31 AM
MetaVia Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
MetaVia Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
7:30 AM
MetaVia Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
MetaVia Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2024
7:30 AM
MetaVia Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
MetaVia Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/02/2024
4:31 PM
Kim Hyung Heon (Reporting)
MetaVia Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
MetaVia Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2024
8:10 AM
MetaVia Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
MetaVia Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2024
7:35 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
7:01 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
7:30 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/07/2024
6:00 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2024
7:07 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2024
3:20 PM
DONG-A ST CO., LTD (Reporting)
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
NeuroBo Pharmaceuticals, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2024
3:10 PM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
7:01 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
7:30 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
7:00 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
Form PRE 14A
07/30/2024
7:30 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/24/2024
11:15 PM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
Form EFFECT
07/24/2024
4:11 PM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
Form 424B3
07/18/2024
7:21 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
Form S-1
Registration statement under Securities Act of 1933  
07/16/2024
7:30 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2024
10:11 AM
DONG-A ST CO., LTD (Reporting)
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
NeuroBo Pharmaceuticals, Inc. (Issuer)
Form 4/A
06/26/2024
8:15 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2024
3:15 PM
DONG-A ST CO., LTD (Filed by)
NeuroBo Pharmaceuticals, Inc. (Subject)
NeuroBo Pharmaceuticals (Subject)
NeuroBo Pharmaceuticals, Inc. (Subject)
Form SC 13D/A
06/25/2024
3:16 PM
DONG-A ST CO., LTD (Reporting)
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
NeuroBo Pharmaceuticals, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
7:21 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
Form 424B5
06/25/2024
7:00 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
The End of Elon Musk…? (Ad)

The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.

Click here to see why the "End of Elon" crowd is about to be wrong again.
06/24/2024
5:01 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
NeuroBo Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:NRBO) was last updated on 6/14/2025 by MarketBeat.com Staff
From Our Partners